Table 3.
Lung function | HOMA-IR | P value for interaction | ||||||
---|---|---|---|---|---|---|---|---|
No- asthma group | Asthma group | |||||||
Beta | SE | P value | Beta | SE | P value | |||
Model 1 | FEV1% predicted | −4.467 | 0.793 | <0.0001 | −1.399 | 2.164 | 0.5185 | 0.6113 |
FVC% predicted | −3.892 | 0.719 | <0.0001 | −3.917 | 2.315 | 0.0916 | 0.6655 | |
FEV1/FVC ratio | −0.007 | 0.004 | 0.0985 | 0.02 | 0.014 | 0.1403 | 0.1962 | |
Model 2 | FEV1% predicted | −4.267 | 0.811 | <0.0001 | −1.221 | 2.159 | 0.5721 | 0.5658 |
FVC% predicted | −3.656 | 0.736 | <0.0001 | −3.368 | 2.414 | 0.1638 | 0.6567 | |
FEV1/FVC ratio | −0.007 | 0.004 | 0.0864 | 0.018 | 0.012 | 0.1592 | 0.1478 |
Data are presented as β coefficients and SE (standard error). Model 1: adjusted for age, sex, and BMI; Model 2: adjusted for age, sex, BMI, smoking status (current smoker), drinking status (>30 mg/day), and exercise status.
HOMA-IR, homeostasis model of assessment of insulin resistance; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second.